BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 18172307)

  • 21. Activating transcription factor 4 promotes angiogenesis of breast cancer through enhanced macrophage recruitment.
    Liu C; Li Z; Wang L; Tong L; He N; Chen Y; Liu Y; Wu Z; Sun P; Xiang R; Ren G; Su W
    Biomed Res Int; 2015; 2015():974615. PubMed ID: 25883982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer.
    Zhang Y; Liu J; Lin J; Zhou L; Song Y; Wei B; Luo X; Chen Z; Chen Y; Xiong J; Xu X; Ding L; Ye Q
    Oncotarget; 2016 Mar; 7(9):9859-75. PubMed ID: 26848522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
    IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopontin induced vascular endothelial growth factor production in dispersed nasal polyp cells through the phosphatidylinositol 3-kinase-protein kinase B and the extracellular signal-regulated kinase 1/2 pathways.
    Du J; Mao H; Ouyang H; Xin Y
    Am J Rhinol Allergy; 2017 Jul; 31(4):35-41. PubMed ID: 28716167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
    Nassehi D
    Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S; Grijalva R; Zhang L; Nguyen NT; Pisters PW; Pollock RE; Yu D
    Cancer Res; 2001 Feb; 61(4):1727-32. PubMed ID: 11245489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
    Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
    Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model.
    Zhang B; Wang D; Ji TF; Shi L; Yu JL
    Oncotarget; 2017 Mar; 8(10):17347-17359. PubMed ID: 28060742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antitumor effect of a novel angiogenesis inhibitor (an octahydronaphthalene derivative) targeting both VEGF receptor and NF-κB pathway.
    Watari K; Nakamura M; Fukunaga Y; Furuno A; Shibata T; Kawahara A; Hosoi F; Kuwano T; Kuwano M; Ono M
    Int J Cancer; 2012 Jul; 131(2):310-21. PubMed ID: 21826646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-3 is a novel target to interfere with tumor vasculature.
    Dentelli P; Rosso A; Olgasi C; Camussi G; Brizzi MF
    Oncogene; 2011 Dec; 30(50):4930-40. PubMed ID: 21643009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.
    Chakraborty G; Jain S; Behera R; Ahmed M; Sharma P; Kumar V; Kundu GC
    Curr Mol Med; 2006 Dec; 6(8):819-30. PubMed ID: 17168734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
    Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
    Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.
    Takahashi F; Akutagawa S; Fukumoto H; Tsukiyama S; Ohe Y; Takahashi K; Fukuchi Y; Saijo N; Nishio K
    Int J Cancer; 2002 Apr; 98(5):707-12. PubMed ID: 11920639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
    Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
    Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
    Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OVA66 promotes tumour angiogenesis and progression through enhancing autocrine VEGF-VEGFR2 signalling.
    Song F; Chen Q; Rao W; Zhang R; Wang Y; Ge H; Wei Q
    EBioMedicine; 2019 Mar; 41():156-166. PubMed ID: 30833190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.